
Qol Holdings
Insurance pharmacies and medical business process outsourcing.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | N/A | IPO | |
Total Funding | 000k |

JPY | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 3 % | 2 % | 6 % | 47 % | 8 % | 7 % | 6 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 9 % | 9 % | 8 % | 8 % | 9 % | 9 % | 9 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 3 % | 3 % | 3 % | 2 % | 3 % | 3 % | 3 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
In October 1992, Masaru Nakamura established Qol Co., Ltd. with a mission to enhance the quality of life through healthcare services. The company began by providing pharmacy services under health insurance, opening its first dispensing pharmacy in 1993. The core idea was to build a network of pharmacies that worked closely with local clinics and hospitals, establishing a foundation of trust and direct service. The company's growth was steady, built on a strategy of opening new stores and executing a series of acquisitions to expand its footprint. A significant operational shift occurred as the company diversified its services. It moved into the Business Process Outsourcing (BPO) segment, offering services like clinical trial support and medical staff dispatch, creating a second pillar for the business alongside its primary pharmacy operations. A major structural milestone was reached in October 2018, when the company transitioned to a holding company structure, changing its name to Qol Holdings Co., Ltd. This move was designed to improve management efficiency and accelerate the growth strategy for its distinct business segments. Now publicly traded on the Tokyo Stock Exchange Prime Market, Qol Holdings continues its journey. The company has pursued significant acquisitions, such as the 2023 agreement to acquire Daiichi Sankyo Espha, to further solidify its market position. Today, under the leadership of President Takashi Nakamura, Qol Holdings operates as a major player in Japan's pharmacy and healthcare services industry.
Investments by Qol Holdings
Edit